Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition

Antibacterial resistance towards the β-lactam (BL) drugs is now ubiquitous, and there is a major global health concern associated with the emergence of new β-lactamases (BLAs) as the primary cause of resistance. In addition to the development of new antibacterial drugs, β-lactamase inhibition is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Zafar, Sun, Jian, Yang, Haikang, Ji, Jingwen, He, Lili, Zhai, Lijuan, Ji, Jinbo, Zhou, Pengjuan, Tang, Dong, Mu, Yangxiu, Wang, Lin, Yang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227086/
https://www.ncbi.nlm.nih.gov/pubmed/35744953
http://dx.doi.org/10.3390/molecules27123832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227086/
https://www.ncbi.nlm.nih.gov/pubmed/35744953
http://dx.doi.org/10.3390/molecules27123832

Ejemplares similares